From NASDAQ:



Growth investors focus on stock growth. Finding great growth stock is difficult due to the increased risk and volatility. However, the Zacks Growth Style Score makes it easy to find cutting-edge growth stocks. Amphastar Pharmaceuticals is currently recommended by the proprietary system. The company’s earnings growth rate is 62.6% in terms of historical EPS growth and its cash flow growth is 25%. Promising upward earnings estimate revisions also prove Amphastar’s superiority. The combination of a Growth Score of B and a Zacks Rank #1 positions the company well for outperformance, attracting growth investors. According to the article, investing in this company could bring in promising returns.

It is recommended to go to Zacks Investors website for the complete list of stocks.



Original: 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock